|By PR Newswire||
|August 18, 2014 10:25 AM EDT||
OTTAWA, Aug. 18, 2014 /CNW/ - Health Canada is advising healthcare professionals and Canadians that it has implemented labelling changes for the class of drugs known as controlled-release opioid pain medicines, to enhance their safe and appropriate use.
The changes provide standardized wording that more clearly outlines the risks and safety concerns associated with controlled-release opioids. The updated guidance also encourages more appropriate patient selection and monitoring.
While an effective pain treatment, opioid medications carry risks and can have serious negative health impacts, even at recommended doses. Their use can also lead to accidental overdose and death. The label changes seek to reduce these risks, which include addiction, misuse and abuse, while preserving access for those who need them most.
There are currently 38 brand name and generic controlled-release opioid medicines in Canada and include, among others, controlled-release versions of morphine, oxycodone, and fentanyl. "Controlled release" medications are designed to be long acting, meaning they produce gradual, steady absorption of the drug in the body over an extended period of time, which allows patients to take them less often.
The changes apply now to all classes of controlled and extended release non-generic opioids.
Similar label changes will soon be implemented for generic opioids.
The approved use for all opioids in this class has been modified to remove use for "moderate" pain. The new label clarifies that these drugs are indicated for the management of pain severe enough to require daily, continuous, long-term opioid treatment that is opioid-responsive and for which alternative treatment options are not adequate. The changes preserve the ability for prescribers to choose appropriate treatment for their patients, but provide clearer guidance on the recommended patient population.
In addition, existing warnings and safety information have been made clearer, including health risks to children from accidental exposure and to newborns exposed during pregnancy. Warnings with respect to opioid addiction potential have also been strengthened and made clearer. As well, the changes standardize label information, and ensure information targeted to patients is easier to read and understand.
Également disponible en français
SOURCE Health Canada
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportuni...
Aug. 24, 2016 08:00 AM EDT Reads: 3,803
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Aug. 24, 2016 08:00 AM EDT Reads: 1,789
Aug. 24, 2016 07:45 AM EDT Reads: 2,046
Aug. 24, 2016 07:15 AM EDT Reads: 1,635
Aug. 24, 2016 07:15 AM EDT Reads: 1,775
Aug. 24, 2016 07:00 AM EDT Reads: 1,722
Aug. 24, 2016 05:00 AM EDT Reads: 2,045
Aug. 24, 2016 04:30 AM EDT Reads: 2,163
Aug. 24, 2016 03:30 AM EDT Reads: 2,903
Aug. 24, 2016 02:00 AM EDT Reads: 1,390
Aug. 24, 2016 01:45 AM EDT Reads: 1,254
Aug. 24, 2016 01:45 AM EDT Reads: 1,853
Aug. 24, 2016 01:00 AM EDT Reads: 1,577
Aug. 24, 2016 12:45 AM EDT Reads: 2,052
Aug. 24, 2016 12:30 AM EDT Reads: 1,853